SEARCH
NEWS & EVENTS
News Archive
CURRENT NEWS
January 9, 2012
Morphotek Enters Into Agreements With Fox Chase Cancer Center to Acquire Clinical Samples for the Development and Validation of Companion Diagnostic Kits
December 2, 2011
Morphotek Terminates Farletuzumab Study (FAR 122) in Platinum-Resistant Ovarian Cancer
June 28, 2011
Morphotek, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
June 27, 2011
Morphotek, Inc. Employees Collect Nearly 9,000 Pounds of Food For Local Families
April 27, 2011
Precis Engineering Provides MEP Engineering, Commissioning for Morphotek Pilot Plant
April 12, 2011
Morphotek Receives Grant to Support Development of Therapeutic Antibodies Against Biowarfare Agents
April 6, 2011
Morphotek, Inc. Receives Beacon Award From CancerCare
April 4, 2011
Morphotek, Inc. Announces Acquisition of Tumor Targeting Assets from Transmolecular, Inc.